Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis

FASEB Journal

Volumn 28, Issue 2, 2014, Pages 836-848

  Rius, Bibiana ^a   Titos, Esther ^a,c   Morán Salvador, Eva ^a   López Vicario, Cristina ^a   García Alonso, Verónica ^a   González Périz, Ana ^a,c   Arroyo, Vicente ^b,c   Clària, Joan ^a,c,d  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Anti inflammatory mediators; Inflammation; Macrophages; NAFLD; Weight loss

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANTIINFLAMMATORY AGENT; CHEMOKINE RECEPTOR CCR7; CYCLOOXYGENASE 2; FATTY ACID; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LEPTIN; LIPID; MESSENGER RNA; MICRORNA; MICRORNA 199A 5P; MICRORNA 219 5P; RESISTIN; RESOLVIN D1; UNCLASSIFIED DRUG; DOCOSAHEXAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC RESTRICTION; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL OBESITY; FATTY ACID BLOOD LEVEL; INSULIN RESISTANCE; LIVER WEIGHT; MACROPHAGE; MALE; MEDIATOR; MOLECULE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WEIGHT REDUCTION; ANIMAL; ANTI-INFLAMMATORY MEDIATORS; C57BL MOUSE; DIET THERAPY; ENZYME IMMUNOASSAY; FATTY LIVER; GENETICS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; METABOLISM; NAFLD; OBESITY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTI-INFLAMMATORY MEDIATORS; INFLAMMATION; MACROPHAGES; NAFLD; WEIGHT LOSS;

ANIMALS; BLOTTING, WESTERN; CALORIC RESTRICTION; DOCOSAHEXAENOIC ACIDS; FATTY LIVER; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; NF-KAPPA B; OBESITY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84897080678     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-235614     Document Type: Article

References (42)

1. Sanyal, A. J. (2005) Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 46-53
2. Angulo, P. (2002) Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221-1231
3. Jou, J., Choi, S. S., Diehl, A. M. (2008) Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin. Liver Dis. 4, 370-379
4. Tilg, H., and Hotamisligil, G. S. (2006) Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 131, 934-945
5. Tilg, H., and Moschen, A. R. (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836-1846
6. González-Périz, A., Horrillo, R., Ferré, N., Gronert, K., Dong, B., Morán-Salvador, E., Titos, E., Martínez-Clemente, M., López- Parra, M., Arroyo, V., Clària, J. (2009) Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 23, 1946-1957
7. Clària, J., Dalli, J., Yacoubian, S., Gao, F., and Serhan, C. N. (2012) Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J. Immunol. 189, 2597-2605
8. Zivkovic, A. M., German, J. B., and Sanyal, A. J. (2007) Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am. J. Clin. Nutr. 8, 285-300
9. Torres, D. M., and Harrison, S. A. (2008) Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 134, 1682-1698
10. Harrison, S. A., and Day, C. P. (2007) Benefits of lifestyle modification in NAFLD. Gut 56, 1760-1769
11. Capristo, E., Miele, L., Forgione, A., Vero, V., Farnetti, S., Mingrone, G., Greco, A. V., Gasbarrini, G., and Grieco, A. (2005) Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH). Eur. Rev. Med. Pharmacol. Sci. 9, 265-268
12. Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., Wing, R. R. (2010) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51,121-129
13. Zelber-Sagi, S., Lotan, R., Shlomai, A., Webb, M., Harrari, G., Buch, A., Nitzan Kaluski, D., Halpern, Z., and Oren, R. (2012) Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J. Hepatol. 56, 1145-1151
14. Xydakis, A. M., Case, C. C., Jones, P. H., Hoogeveen, R. C., Liu, M. Y., Smith, E. O., Nelson, K. W., and Ballantyne, C. M. (2004) Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J. Clin. Endocrinol. Metab. 89, 2697-2703
15. Li, P., Lu, M., Nguyen, M. T., Bae, E. J., Chapman, J., Feng, D., Hawkins, M., Pessin, J. E., Sears, D. D., Nguyen, A. K., Amidi, A., Watkins, S. M., Nguyen, U., Olefsky, JM. (2010) Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J. Biol. Chem. 285,15333-15345
16. Huang, M. A., Greenson, J. K., Chao, C., Anderson, L., Peterman, D., Jacobson, J., Emick, D., Lok, A. S., Conjeevaram, H. S. (2005) One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am. J. Gastroenterol. 100, 1072-1081
17. Sun, Y. P., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S. P., Petasis, N. A., Serhan, C. N. (2007) Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282, 9323-9334
18. Titos, E., Rius, B., González-Périz, A., López-Vicario, C., Morán- Salvador, E., Martínez-Clemente, M., Arroyo, V., Clària, J. (2011) Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J. Immunol. 187, 5408-5418
19. Rius, B., López-Vicario, C., González-Périz, A., Morán-Salvador, E., García-Alonso, V., Clária, J., and Titos, E. (2012) Resolution of inflammation in obesity-induced liver disease. Front. Immunol. 3, 257
20. Recchiuti, A., Krishnamoorthy, S., Fredman, G., Chiang, N., and Serhan, C. N. (2011) MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. FASEB J. 25, 544-560
21. Kosteli, A., Sugaru, E., Haemmerle, G., Martin, J. F., Lei, J., Zechner, R., Ferrante, A. W. Jr. (2010) Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Invest. 120, 3466-3479
22. Klassen, L. W., Thiele, G. M., Duryee, M. J., Schaffert, C. S., DeVeney, A. L., Hunter, C. D., Olinga, P., and Tuma, D. J. (2008) An in vitro method of alcoholic liver injury using precision-cut liver slices from rats. Biochem. Pharmacol. 76, 426-436
23. Aron-Wisnewsky, J., Minville, C., Tordjman, J., Lévy, P., Bouillot, J. L., Basdevant, A., Bedossa, P., Clément, K., Pépin, J. L. (2012) Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J. Hepatol. 56, 225-233
24. Bartel, D. P. (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233
25. Mantovani, A. (2010) Molecular pathways linking inflammation and cancer Curr. Mol. Med. 10, 369-373
26. Serhan, C. N., Chiang, N., Van Dyke, T. E. (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349-361
27. Serhan, C. N. (2010) Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? Am. J. Pathol. 177, 1576-1591
28. Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., Gronert, K. (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192, 1197-1204
29. González-Périz, A., Planagumà, A., Gronert, K., Miquel, R., López-Parra, M., Titos, E., Horrillo, R., Ferré, N., Deulofeu, R., Arroyo, V., Rodés, J., Clària, J. (2006) Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J. 20, 2537-2539
30. Parker, H. M., Johnson, N. A., Burdon, C. A., Cohn, J. S., O'Connor, H. T., and George, J. (2012) Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J. Hepatol. 56, 944-951
31. Masterton, G. S., Plevris, J. N., and Hayes, P. C. (2010) Review article: omega-3 fatty acids: a promising novel therapy for non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 31, 679-692
32. López-Vicario, C., González-Périz, A., Rius, B., Morán-Salvador, E., García-Alonso, V., Lozano, J. J., Bataller, R., Cofán, M., Kang, J. X., Arroyo, V., Clària, J., Titos, E. (2013) Molecular interplay between -5/-6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. [E-pub ahead of print] Gut. 10.1136/gutjnl-2012-303179
33. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35
34. Hellmann, J., Tang, Y., Kosuri, M., Bhatnagar, A., and Spite, M. (2011) Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 25, 2399
35. Fredman, G., Li, Y., Dalli, J., Chiang, N., and Serhan, C. N. (2012) Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA. Sci. Rep. 2, 639
36. Gonsalves, C. S., and Kalra, V. K. (2010) Hypoxia-mediated expression of 5-lipoxygenase-activating protein involves HIF- 1alpha and NF-kappaB and microRNAs 135a and 199a-5p. J. Immunol. 184, 3878-3888
37. Schnitger, A. K., Machova, A., Mueller, R. U., Androulidaki, A., Schermer, B., Pasparakis, M., Krönke, M., Papadopoulou, N. (2011) Listeria monocytogenes infection in macrophages induces vacuolar-dependent host miRNA response. PLoS One 6, e27435
38. Szabo, G., Sarnow, P., and Bala, S. (2012) MicroRNA silencing and the development of novel therapies for liver disease. J. Hepatol. 57, 462-466
39. Roderburg, C., Urban, G. W., Bettermann, K., Vucur, M., Zimmermann, H., Schmidt, S., Janssen, J., Koppe, C., Knolle, P., Castoldi, M., Tacke, F., Trautwein, C., Luedde, T. (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209-218
40. Sackmann-Sala, L., Berryman, D. E., Munn, R. D., Lubbers, E. R., Kopchick, J. J. (2012) Heterogeneity among white adipose tissue depots in male C57BL/6J mice. Obesity 20, 101-111
41. Clària, J., Nguyen, B. T., Madenci, A., Ozaki, C. K., Serhan, C. N. (2013) Diversity of lipid mediators in human adipose tissue depots. Am. J. Physiol Cell Physiol. 15, C1141-C1149
42. Hudert, C. A., Weylandt, K. H., Lu, Y., Wang, J., Hong, S., Dignass, A., Serhan, C. N., Kang, J. X. (2006) Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc. Natl. Acad. Sci. U. S. A. 103, 11276-11281